Fangyun Wu

552 total citations · 1 hit paper
15 papers, 321 citations indexed

About

Fangyun Wu is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Toxicology. According to data from OpenAlex, Fangyun Wu has authored 15 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Oncology and 3 papers in Toxicology. Recurrent topics in Fangyun Wu's work include COVID-19 and healthcare impacts (3 papers), Global Cancer Incidence and Screening (2 papers) and Drug-Induced Adverse Reactions (2 papers). Fangyun Wu is often cited by papers focused on COVID-19 and healthcare impacts (3 papers), Global Cancer Incidence and Screening (2 papers) and Drug-Induced Adverse Reactions (2 papers). Fangyun Wu collaborates with scholars based in Canada, Qatar and China. Fangyun Wu's co-authors include Tara Kiran, Michael Green, Richard H. Glazier, Eliot Frymire, Alexander Kopp, Mandana Vahabi, Kristian B. Filion, Aïsha Lofters, Michael J. Paterson and Jennifer W. Wu and has published in prestigious journals such as JAMA, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Fangyun Wu

12 papers receiving 312 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario, Canada

2021 260 citations Richard H. Glazier, Michael Green et al. Canadian Medical Association Journal profile →

Peers

Fangyun Wu

GHP

PHEOH

ONCOL

EPIDE

CP

Andrew Wallach United States

Robert Gianforcaro United States

Dana Aronson Schinasi United States

Andrés Gempeler Colombia

Daniela Nasner Colombia

Sílvia Lopes Portugal

Christina A. Olson United States

Prajwal Paudel Nepal

Jamie L. Kissee United States

Nomfuneko Sithole South Africa

Andrew Wallach United States

Fangyun Wu

164 ×1.2

GHP

136 ×1.0

PHEOH

109 ×0.8

ONCOL

33 ×0.8

EPIDE

50 ×1.4

CP

Citations per year, relative to Fangyun Wu Fangyun Wu (= 1×) peers Andrew Wallach

Countries citing papers authored by Fangyun Wu

Since Specialization

Citations

This map shows the geographic impact of Fangyun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyun Wu more than expected).

Fields of papers citing papers by Fangyun Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyun Wu. The network helps show where Fangyun Wu may publish in the future.

Co-authorship network of co-authors of Fangyun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyun Wu. A scholar is included among the top collaborators of Fangyun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyun Wu. Fangyun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Krahn, Murray, Fangyun Wu, Matthew B. Stanbrook, et al.. (2025). Understanding the Growing Burden of Malignant Pleural Effusion – Epidemiology, Healthcare Utilization, and Cost: A Canadian Perspective. Respiration. 104(6). 421–433. 1 indexed citations

2.

Akbar, S. M. F., Joanna Yang, Tony Antoniou, et al.. (2024). Characteristics of Opioid Toxicity Deaths Among Adolescents and Young Adults in Ontario Prior To and During the COVID-19 Pandemic. Journal of Adolescent Health. 75(1). 35–42.

3.

Leece, Pamela, Joanna C. Yang, Gillian Kolla, et al.. (2024). Trends, characteristics, and circumstances surrounding stimulant toxicity deaths in Ontario, Canada from 2018 to 2021. Journal of Substance Use and Addiction Treatment. 170. 209614–209614.

4.

Lee, Erika Yue, Aaron M. Drucker, Nick Daneman, et al.. (2024). Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions. JAMA. 332(9). 730–730. 6 indexed citations

5.

Lee, Erika Yue, Tara Gomes, Aaron M. Drucker, et al.. (2024). Oral Antibiotics and the Risk of Serious Cutaneous Adverse Drug Reactions. Journal of Allergy and Clinical Immunology. 153(2). AB164–AB164. 1 indexed citations

6.

Howard, Michelle, Fangyun Wu, Tara Kiran, et al.. (2023). The Impact of the COVID 19 Pandemic on Continuity of Care with Ontario Family Physicians. PubMed Central. 3671–3671. 1 indexed citations

7.

Lix, Lisa M., Christel Renoux, Carolina Moriello, et al.. (2023). Validity of diagnoses of SARS-CoV-2 infection in Canadian administrative health data: a multiprovince, population-based cohort study. CMAJ Open. 11(5). E790–E798. 1 indexed citations

8.

Lofters, Aïsha, Fangyun Wu, Eliot Frymire, et al.. (2023). Cancer Screening Disparities Before and After the COVID-19 Pandemic. JAMA Network Open. 6(11). e2343796–e2343796. 20 indexed citations

9.

Wu, Fangyun, et al.. (2022). Tunable shape memory properties of highly stretchable poly(ester urea) random copolymers based on α-amino acids. Soft Matter. 18(41). 7959–7967. 3 indexed citations

10.

Fisher, Anat, J. Michael Paterson, Fangyun Wu, et al.. (2022). Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study. PLoS ONE. 17(12). e0277623–e0277623. 1 indexed citations

11.

Widdifield, Jessica, et al.. (2022). Sex-related differences in health-care use in adult patients with inflammatory arthritis in Ontario, Canada: a population-based cohort study. The Lancet Rheumatology. 4. S12–S13. 1 indexed citations

12.

Kiran, Tara, Fangyun Wu, Lidija Latifovic, Richard H. Glazier, & Eliot Frymire. (2022). Did the COVID-19 pandemic cause family physicians to stop practice? Results from Ontario, Canada. PubMed Central. 3018–3018.

13.

Glazier, Richard H., Michael Green, Fangyun Wu, et al.. (2021). Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario, Canada. Canadian Medical Association Journal. 193(6). E200–E210. 260 indexed citations breakdown →

14.

Dormuth, Colin R., Anat Fisher, Fangyun Wu, et al.. (2021). Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. JAMA Network Open. 4(4). e215329–e215329. 13 indexed citations

15.

Wu, Jennifer W., Laurent Azoulay, Anjie Huang, et al.. (2018). Identification of incident pancreatic cancer in Ontario administrative health data: A validation study. Pharmacoepidemiology and Drug Safety. 29(S1). 78–85. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact